首页|3,6-双取代咪唑并[1,2-a]嘧啶类MNK小分子抑制剂的设计、合成及抗肿瘤活性研究

3,6-双取代咪唑并[1,2-a]嘧啶类MNK小分子抑制剂的设计、合成及抗肿瘤活性研究

扫码查看
目的 设计并合成3,6-双取代咪唑并[1,2-a]嘧啶类MNK抑制剂,并对其进行抗肿瘤活性研究.方法 以5-溴嘧啶-2-胺为起始原料,通过环合反应得到关键中间体6-溴咪唑并[1,2-a]嘧啶,随后通过Suzuki偶联、碘代、酰胺化等反应得到目标化合物8a~8x.采用HTRF法,以CGP57380为阳性对照,测试目标化合物在浓度为1 µmol·L-1时对MNK的抑制活性.采用MTT法,以CGP57380为阳性对照,测试目标化合物对人结肠癌细胞HCT-116的抗增殖活性.结果 设计合成24个未见文献报道的化合物,其结构均经1H-NMR、13C-NMR、LC-MS确证.酶活性测试结果表明大部分化合物对MNK的抑制作用较弱,抑制率小于20%.细胞活性测试结果表明化合物8h、8o、8r、8u和8w对HCT-116细胞表现出中等强度的抗增殖作用,GI50值在10 μmol·L-1左右,优于阳性对照CGP57380.结论 初步研究了 3,6-双取代咪唑并[1,2-a]嘧啶母核在MNK抑制剂中的应用,为进一步开发该类MNK抑制剂奠定了一定基础.
Design,synthesis and antitumor activity of 3,6-disubstituted imidazo[1,2-a]pyrimidines as MNK inhibitors
Based on pyrido[3,2-d]pyrimidine derivatives with MNK inhibitory activity,a series of imidazo[1,2-a]pyrimidine derivatives were designed and synthesized via a scaffold hopping strategy.The key intermediate 6-bromoimidazo[1,2-a]pyrimidine was obtained from 5-bromopyrimidine-2-amine,and the target compounds 8a-8x were obtained through Suzuki coupling,iodination,amidation reaction,etc.The inhibitory rate of the target compounds against MNKs at 1 μmol·L-1 was measured by HTRF method,and the antiproliferation activity of the target compounds against human colon cancer cell line HCT-116 was measured by MTT method.The results indicated that most of the compounds displayed weak MNK inhibitory activity.Among them,compound 8r showed the most potent MNK inhibitory activity with an inhibitory rate of 64%and 59%at 1 µmol·L-1 against MNK1 and MNK2,respectively.The antiproliferation activity demonstrated that 8h,8o,8r,8u and 8w displayed moderate inhibitory activities against HCT-116 cell line with GI50 values of 9.68-13.06 μmo1·L-1.

MNK3,6-disubstituted imidazo[1,2-a]pyrimidinesantitumor

李景欢、邢坤、赵临襄

展开 >

沈阳药科大学制药工程学院,辽宁沈阳 110016

MNK激酶 3,6-双取代咪唑并[1,2-a]嘧啶类化合物 抗肿瘤

2024

中国药物化学杂志
沈阳药科大学,中国药学会

中国药物化学杂志

CSTPCD
影响因子:0.463
ISSN:1005-0108
年,卷(期):2024.34(4)
  • 1